Search for: "WATSON PHARMACEUTICALS "
Results 121 - 140
of 360
Sorted by Relevance
|
Sort by Date
13 Jul 2011, 4:09 pm
Watsons ruling was in response to a request from the city for a summary judgment against Arnold. [read post]
3 Jun 2010, 2:23 pm
In 2003, pursuant to the Hatch-Waxman Act, two generic companies, Watson Pharmaceuticals and Paddock Laboratories (in partnership with Par Pharmaceuticals), each filed Abbreviated New Drug Applications ("ANDAs") with the FDA, seeking to market much cheaper, generic versions of AndroGel well before the expiration of Solvay's patent in 2020. [read post]
11 Mar 2012, 3:32 pm
Apotex Pty Ltd v AstraZeneca AB (No 2) [2012] FCA 142 (28 February 2012) Watson Pharma Pty Ltd v AstraZeneca AB [2012] FCA 200 (9 March 2012) Interlocutory injunctions – prima facie case – balance of convenience – whether additional evidence provides grounds to vary previous findings At least five Australian pharmaceutical manufacturers are now ready to launch generic versions of cholesterol-lowering drug CRESTOR, while being barred from doing so pending the… [read post]
31 Oct 2007, 4:37 am
"Even so, Watson Chemical advertises that it makes active pharmaceutical ingredients. [read post]
21 Apr 2011, 3:09 pm
“It is important to ensure there is no possibility of a breakdown in risk management systems on hazardous sites and the visits will reinforce this,” Watson added. [read post]
23 Oct 2012, 6:30 am
Watson Pharmaceuticals, Inc., No. 12-416 (U.S. [read post]
28 Sep 2012, 11:15 am
Watson Pharmaceuticals, Inc., No. 10-12729, where the Eleventh Circuit upheld reverse payments -- finding no antitrust violation in settlements involving generic Androgel. [read post]
16 Sep 2012, 5:12 pm
Watson Pharmaceuticals, Inc., 677 F.3d 1298 (11th Cir. 2012). [read post]
23 May 2014, 6:08 pm
Watson Pharma., Inc., No. 2013-1409 (Fed. [read post]
25 Feb 2010, 6:18 am
Watson Pharmaceuticals, Inc., Watson was selling a gout medication, which, it argued, was grandfathered. [read post]
12 Nov 2012, 4:14 pm
Ortho Pharmaceutical Corp., 615 F. [read post]
1 Feb 2013, 10:32 am
Watson Pharmaceuticals. [read post]
3 May 2012, 6:26 pm
The ruling stems from a 2009 patent infringement complaint filed by Allergan against Watson Pharmaceuticals, in its attempts to prevent Watson from filing an abbreviated new drug application with the FDA for the generic version of Sanctura. [read post]
2 Jun 2017, 3:06 am
Thomas Watson, Robert H. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun Pharmaceutical… [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma… [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun Pharmaceutical… [read post]
10 Jan 2012, 12:43 pm
Mamula, Reporter for the Pittsburgh Business Times: Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs have sued generic drugmaker Mylan Inc. for patent infringement in connection with its plans to market pioglitazone hydrochloride and extended release metformin hydrochloride tablets, Canonsburg-based Mylan announced Monday. [read post]
14 Mar 2011, 4:31 am
From a press release, Morristown, NJ, 14 March 2011:Watson Pharmaceuticals, Inc. , today announced that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) does not infringe United States Patent Nos. 6,200,604 or 6,974,590 (the '604 and '590 Patents) and that the '604 and '590 Patents are invalid. [read post]
30 Nov 2012, 12:21 pm
Currently, Ranbaxy is responsible for about 40% of the U.S. market for the popular cholesterol drug; other companies that distribute similar products are Mylan and Watson Pharmaceuticals. [read post]
